Company Overview and News

28
Most South-east Asia shares fall ahead of Fed decision, Philippines down over 2pc

2018-06-13 malaymail
SINGAPORE, June 13 — Most South-east Asian stock markets declined today, in line with broader Asia ahead of the US Federal Reserve's policy decision which could give cues on future rate hikes.
UOVEF JGSMY DBSDY PBLOF SVTMF JGS BDOUY SM 1295 U11 BDOUF BDO D05 SMIVY DBSDF UOVEY JGSHF

5
SMEs plan to go hi-tech

2018-06-11 thestar.com.my
SMALL and medium enterprises (SMEs) in Malaysia plan to invest more in technology in order to succeed under increasingly challenging conditions.
UOVEF UOVEY U11

8
South-east Asia stocks fall on heightened global caution

2018-06-08 malaymail
SINGAPORE, June 8 — South-east Asian stock markets fell today on heightened caution ahead of a key meeting of global leaders and amid expectations that the Federal Reserve will raise US interest rates next week.
1155 1023 UOVEF MLYBY MLYNF UOVEY U11 CIMDF

8
Where Banking Is Light Years Ahead Of The World – ValueWalk Premium

2018-05-28 valuewalkpremium
The basic business of banking hasn’t changed a lot since the 18th century BC… when gold stored for safekeeping in temples of Babylon was loaned out by priests.
UOVEF UOVEY U11 O39

5
Decade-low costs for dollar loans poised to rise for India Inc.

2018-05-28 livemint
Sydney/Mumbai: The good days for India Inc. in the offshore syndicated loans market may soon be over, as foreign banks pinched by their own rising borrowing costs balk at the lowest lending rates in a decade.
UOVEF UOVEY U11

5
1MDB scandal: A timeline - Channel NewsAsia

2018-05-22 channelnewsasia
Former Malaysian Prime Minister Najib Razak is expected to turn up at the Malaysian Anti-Corruption Commission's (MACC) headquarters on Tuesday morning (May 22) to record a statement to facilitate investigations into the case involving 1Malaysia Development Berhad (1MDB), Malaysia's state investment firm.
UOVEF UOVEY U11

5
Singapore to implement e-invoice framework based on Europe’s PEPPOL

2018-05-21 channelnewsasia
SINGAPORE: Singapore will become the first Asian country to implement an electronic invoicing standard based on a similar process used in Europe.
UOVEF UOVEY OV8 U11

5
UOB ceasing foreign currency banknotes import in Taiwan - sources

2018-05-18 reuters
TAIPEI, May 18 (Reuters) - United Overseas Bank (UOB) will stop supplying foreign currency banknotes to lenders in Taiwan from June 18 amid concern on tighter anti-money laundering rules in the region, four sources with direct knowledge of the matter said.
UOVEF FRBA UOVEY U11

52
Malaysia Finance Minister Seen as Safe Pick as Budget Risks Rise - Bloomberg

2018-05-14 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
83SF BCS.PR BCS.PRD UOVEF BCS BCS.PRC 83SK BCS.PRA UOVEY INTC U11 47MC

5
Trade war ultimately disruptive to global economy: Heng Swee Keat

2018-05-03 channelnewsasia
SINGAPORE: Trade friction escalating to a trade war will ultimately be disruptive to the global economy, warned Finance Minister Heng Swee Keat on Thursday (May 3).
UOVEF UOVEY U11

5
The Power of Diversity

2018-05-02 scmp
In a global economy, companies that seek to grow beyond the local market need to employ a pool of talent representing diverse points of view and the knowledge to succeed. Diversity can be a competitive differentiator.
FOSUF UOVEF 0656 UOVEY 0806 VPGLF FOSUY U11

5
From the Dean

2018-05-02 scmp
The principle that people should be hired for positions, and promoted or rewarded, solely on the basis of their talents and performance, and not because of their gender, ethnic origins or other functionally irrelevant demographic attributes, is widely accepted today. But beyond a sense of being on the right side of social progress, does employing a more diverse workforce boost performance?
FOSUF UOVEF 0656 UOVEY 0806 VPGLF FOSUY U11

5
Inside Track

2018-05-02 scmp
An internship can provide the all-important building blocks for developing a future career. The process can include learning through practical experience, gaining insights into industry trends, and forming the first threads of a professional network. Chairman of Value Partners Group, Dato’ Cheah Cheng Hye, and CEO - Greater China of the United Overseas Bank (UOB), Mrs Christine Ip, explain how internships can provide a valuable learning curve for students and make a big difference when they enter the job market.
UOVEF UOVEY 0806 VPGLF U11

5
Women Leading the Way

2018-05-02 scmp
The HKUST Business School boasts a list of impressive female business leaders and entrepreneurs among its alumni. Four of them share their thoughts on gender diversity in leadership positions, the opportunities and challenges faced by talented women, and the approaches that have made them successful in their careers. They are Christine Ip (HKUST MBA alumna), CEO - Greater China of United Overseas Bank; Sophia Leung (Kellogg-HKUST EMBA alumna), Asia Pacific CIO of J.
UOVEF UOVEY U11

8
CEO of Southeast Asia’s largest bank discusses what's next after record quarter

2018-04-30 cnbc
DBS Group, the largest bank in Southeast Asia, on Monday said net profit in the first three months of 2018 rose to its highest ever as its loans business grew on the back of a strengthening economy in its home country, Singapore.
UOVEF UOVEY U11 O39

Related Articles

PRTO: Proteon Therapeutics Analysis and Research Report

2018-06-11 - Asif

Overview Proteon Therapeutics is a late-stage biopharmaceutical company focused on the development of novel, first-in-class pharmaceuticals to address the needs of patients with renal and vascular disease. The company's product candidate, vonapanitase, is a recombinant human elastase that Proteon Therapeutics is developing to improve vascular access outcomes in patients with chronic kidney disease, or CKD, undergoing or planning for hemodialysis, a lifesaving treatment that cannot be conducted without a functioning vascular access. The company believe data from its completed Phase 2 and Phase 3 clinical trials of vonapanitase support that a one-time, local application of investigational vonapanitase during surgical creation of a radiocephalic fistula for hemodialysis may improve fistula use for hemodialysis and secondary patency (time to fistula abandonment), thereby improving patient outcomes and reducing the burden on patients and the healthcare system. Arteriovenous fistu...

GALE: Galena Biopharma Analysis and Research Report

2018-06-11 - Asif

Overview Galena Biopharma is a clinical-stage biopharmaceutical company focused on novel cancer immunotherapeutics for a broad range of cancer indications. The company's lead product candidate, galinpepimut-S, or GPS, is a cancer i unotherapeutic agent licensed from Memorial Sloan Kettering Cancer Center, or MSK, that targets the Wilms tumor 1, or WT1, protein, which is present in 20 or more cancer types. Based on its mechanism of action as a directly immunizing agent, GPS has the potential as a monotherapy or in combination with other immunotherapeutic agents to address a broad spectrum of hematologic, or blood, cancers and solid tumor indications. Phase 2 clinical trials for GPS have been completed and Galena Biopharma has planned Phase 3 clinical trials (pending funding availability) for two indications, acute myeloid leukemia, or AML, and malignant pleural mesothelioma, or MPM. GPS is also in development as a potential treatment for multiple myeloma, or MM, and ovarian can...

STML: Stemline Therapeutics Analysis and Research Report

2018-06-11 - Asif

Overview Stemline Therapeutics was incorporated under the laws of the State of Delaware in August 2003. Stemline Therapeutics is a clinical stage biopharmaceutical company focused on discovering, acquiring, developing and potentially commercializing innovative oncology therapeutics that target difficult to treat cancers. The company's clinical pipeline includes: SL-401, SL-801, and SL-701. SL-401 pivotal data; plans for registration and potential commercialization: SL-401 has completed a pivotal trial in patients with blastic plasmacytoid dendritic cell neoplasm, or BPDCN, and has successfully met the primary endpoint of the trial. SL-401 is a targeted therapy directed to the interleukin-3 receptor-a, or CD123. SL-401 was granted breakthrough therapy designation, or BTD, by the U.S. Food and Drug Administration, or FDA, for the treatment of patients with BPDCN. Based on the trial results and other data, the company expect to complete submission of a rolling Biologics License...

CUSIP: 911271302